Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 72 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-06 Ferguson Toby Chief Medical Officer Grant or award +45,000 183,914
2026-02-06 Ferguson Toby Chief Medical Officer Grant or award · Stock Option (Right to Buy) +210,000 210,000
2025-08-18 Ferguson Toby Chief Medical Officer Sale −19,000 $3.73 $71K 138,914
2025-04-02 Ferguson Toby Chief Medical Officer Sale −10,086 $3.43 $35K 157,914
2025-02-21 Ferguson Toby Chief Medical Officer Grant or award +63,000 168,000
2025-02-21 Ferguson Toby Chief Medical Officer Grant or award · Stock Option (Right to Buy) +126,000 126,000
2024-04-01 Ferguson Toby Chief Medical Officer Grant or award +105,000 105,000
2024-03-25 Ferguson Toby Chief Medical Officer Grant or award · Stock Option (Right to Buy) +210,000 210,000

Page 1 of 1 · 8 trades